More Cochlear Limited news
Cochlear LimitedASX: COH

Adverse appeal decision in the US patent infringement case

Mar 16, 2020 at 10:31 PM EDT · Issued by Cochlear Limited

Filed with ASX · Mar 16, 2020 at 10:31 PM EDT

On 6ix: 6ix.com/news/adverse-appeal-decision-in-the-us-patent-infringement-case

Watch Cochlear's latest call↗Cochlear (ASX:COH) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cochlear (ASX:COH) Q4 2026 Earnings Call↗

Cochlear Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cochlear Limited on 6ix

Story so far

  • COH - Profile Plus FDA ApprovalJun 17, 2019
  • COH - Ruling in USA Patent Infringement CaseNov 5, 2018

Earlier from Cochlear

  • Cochlear withdraws FY20 earnings guidance due to coronavirusMar 15, 2020
  • HY20 Result Presentation SlidesFeb 17, 2020
  • HY20 Result ASX & Media ReleaseFeb 17, 2020
  • Cochlear reduces earnings guidance due to coronavirusFeb 10, 2020
  • 2019 Chairmans AGM Address to ShareholdersOct 21, 2019

Later from Cochlear

  • Trading HaltMar 24, 2020
  • Cochlear Limited announces capital raising to enhance liquidMar 24, 2020
  • Investor PresentationMar 24, 2020
  • Successful completion of A$880M Institutional PlacementMar 25, 2020
  • Cochlear Share Purchase Plan Offer OpenMar 31, 2020
All Cochlear news releases↗

Follow Cochlear into a list and get an email when it puts out news.

Follow Cochlear
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer